Atypical Moles (Dysplastic Nevi)

What Is an Atypical Mole?

An atypical mole — known to pathologists as a dysplastic nevus — is a benign growth of pigment-producing cells (melanocytes) in the skin. It is a type of ordinary mole. It tends to be larger than a common mole, with a less regular border and more than one shade of color, which is why it can look concerning to both patients and clinicians.

The single most important fact about atypical moles is this: they are benign. A dysplastic nevus is not cancer, and the overwhelming majority never become cancer. They matter for two reasons. First, having several of them is a marker that a person is at higher-than-average risk of developing melanoma somewhere on the skin over their lifetime. Second, because an atypical mole can share features with early melanoma, it is sometimes biopsied to be certain of the diagnosis. Those are real reasons to pay attention — but they are different from the lesion itself being dangerous.

How to Recognize One

Atypical moles often share some — but not all — of the "ABCDE" features used to screen for melanoma:

• Asymmetry: One half may not match the other
• Border: Edges can be irregular, notched, or fade gradually into the surrounding skin
• Color: Often more than one color — tan, brown, pink, or a darker center with a lighter rim ("fried-egg" appearance)
• Diameter: Frequently larger than a pencil eraser (more than 6 mm), though size alone means little
• Evolving: Stable atypical moles are common; a mole that is changing is what warrants attention

Many people have one or a few atypical moles. Some people have many, sometimes dozens — a pattern historically called dysplastic (or atypical) nevus syndrome, which is associated with higher melanoma risk, particularly when there is also a family history of melanoma.

Causes & Risk Factors

Atypical moles arise from the same general factors that influence ordinary moles, with a strong inherited component:

• Genetics and family history: Atypical moles often run in families; a tendency toward many moles is partly inherited
• Total number of moles: People who form many moles are more likely to form atypical ones
• Sun exposure: Ultraviolet exposure, especially intermittent intense exposure and sunburns in youth, contributes to mole development
• Fair skin type: More common in people with lighter skin, hair, and eyes

Having atypical moles, a high mole count, fair skin, a history of significant sun exposure, or a personal or family history of melanoma all raise melanoma risk — and they compound when combined.

Diagnosis

Most atypical moles are identified on a skin examination, aided by dermoscopy (a handheld magnifier with polarized light that reveals pigment patterns beneath the surface). Dermoscopy lets a trained dermatologist distinguish the orderly patterns typical of a benign mole from the disorganized patterns that raise concern.

When a lesion cannot be confidently called benign — or when it is changing — a biopsy is performed and the tissue is examined under the microscope. The pathologist assesses how orderly the melanocytes and surrounding architecture appear and assigns a grade of atypia.

Grading: Mild, Moderate, and Severe

When a dysplastic nevus is examined under the microscope, the degree of disorder is usually described as mild, moderate, or severe (some laboratories use a two-tier "low-grade" versus "high-grade" system instead). The grade describes how far the cells and architecture stray from a perfectly ordinary mole — not a percentage chance of becoming cancer.

• Mild atypia: Closest to an ordinary mole. Benign, with very little diagnostic uncertainty.
• Moderate atypia: An intermediate appearance. Benign, but the middle category where pathologists most often disagree.
• Severe atypia: The most disordered end of the benign spectrum. Still a benign diagnosis, but its features overlap most with early melanoma, so it is treated with the greatest caution.

It is worth knowing that this grading is subjective. Studies have repeatedly shown meaningful disagreement between pathologists — and even by the same pathologist on different days — particularly in the moderate range. A grade is a useful guide to management, not a precise measurement.

Are Atypical Moles "Pre-Melanoma"? A Misnomer

Atypical moles are frequently, and incorrectly, described as "pre-melanoma" or "pre-cancerous." This is a misnomer, and the distinction matters.

A true precancer is a lesion on a defined path toward cancer if left alone — an actinic keratosis, for example, is a recognized direct precursor to squamous cell carcinoma. A dysplastic nevus is not that. It is a benign lesion and a marker of risk, not an obligate precursor. The risk it signals applies to the person's skin as a whole, not to that specific spot. Any individual atypical mole has only a very small chance of ever transforming, and most melanomas do not arise from a pre-existing dysplastic nevus at all — a large share develop on previously normal-looking skin (de novo). Comprehensive reviews of the evidence conclude that the dysplastic nevus is a type of melanocytic nevus and should be managed like other benign moles.

Calling these lesions "pre-melanoma" overstates the danger of the individual mole, fuels anxiety, and can drive unnecessary procedures. The accurate framing is: a benign mole that, in numbers, tells us to watch the whole patient more closely.

Treatment & Management

Because an atypical mole is benign, removing it is not required simply because of what it is. A biopsy is done when the diagnosis is uncertain or the lesion is changing; once a benign dysplastic nevus is diagnosed, management is usually straightforward.

A common point of confusion arises when a biopsy report notes that the mole was removed with a positive margin — meaning a small amount of the benign mole remains in the skin. Historically, many of these were automatically cut out again ("re-excised"). Current evidence and expert consensus no longer support routine re-excision for lower grades:

• Mildly dysplastic nevi with a positive margin: Re-excision is not recommended. Clinical observation is appropriate.
• Moderately dysplastic nevi with a positive margin: Observation is a reasonable option. A multicenter study following hundreds of such moles for an average of nearly seven years found no melanomas developing at the observed biopsy sites, supporting watchful observation rather than reflexive re-excision in many cases.
• Severely dysplastic nevi with a positive margin: Re-excision is still generally recommended, because this grade overlaps most with early melanoma and carries the greatest diagnostic uncertainty.

These positions come from the Pigmented Lesion Subcommittee of the Melanoma Prevention Working Group and subsequent outcome studies. The practical takeaway: a positive margin on a mild or moderate dysplastic nevus is usually not a reason for another procedure. If re-excision is recommended for a mild or moderate lesion, it is reasonable to ask why, and what the grade was.

None of this changes the value of ongoing surveillance. Whether or not a specific mole is re-excised, a person with atypical moles benefits from regular skin checks of the entire skin surface.

Prevention & Monitoring

You cannot prevent atypical moles, but you can reduce melanoma risk and catch problems early:

• Regular full-body skin exams with a dermatologist, at an interval matched to your risk
• Monthly skin self-exams, learning your own moles so you can notice change
• Watch for the "ugly duckling" — the mole that stands out from the rest, or one that is changing
• Sun protection: Broad-spectrum SPF 30+, protective clothing, and avoiding tanning beds
• Baseline photography (Total Body Photography) for people with many moles, so change can be compared objectively over time

When to See a Doctor

See a dermatologist if you notice a mole that is new, changing in size, shape, or color, or that simply looks different from your others — especially if it itches, bleeds, or will not heal. If you have many moles, atypical moles, or a personal or family history of melanoma, establish care for periodic skin exams rather than waiting for a problem.

And if you have been told an atypical mole was removed with a positive margin, know that for mild and many moderate lesions, careful observation — not another excision — is consistent with current evidence. It is a fair and useful conversation to have with your dermatologist.

References

1. Kim CC, Swetter SM, Curiel-Lewandrowski C, et al. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. JAMA Dermatology. 2015;151(2):212–218. pubmed.ncbi.nlm.nih.gov
2. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins: A Multicenter Study. JAMA Dermatology. 2018;154(12):1390–1392. jamanetwork.com
3. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part I. Historical, histologic, and clinical aspects. Journal of the American Academy of Dermatology. 2012;67(1):1.e1–16. pubmed.ncbi.nlm.nih.gov
4. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part II. Molecular aspects and clinical management. Journal of the American Academy of Dermatology. 2012;67(1):19.e1–12. pubmed.ncbi.nlm.nih.gov
5. Dysplastic nevi with severe atypia: Long-term outcomes in patients with and without re-excision. Journal of the American Academy of Dermatology. 2016. jaad.org
6. The Association of Nevus-Associated Melanoma with Common or Dysplastic Melanocytic Nevus: A Systematic Review and Meta-Analysis. pmc.ncbi.nlm.nih.gov
7. Dysplastic nevus part II: Molecular/genetic profiles and management. Journal of the American Academy of Dermatology. 2023. jaad.org